Keybank National Association Novartis Ag Transaction History

Keybank National Association

$25.5 Billion
Q3 2024

A detailed history of Keybank National Association transactions in Novartis Ag stock. As of the latest transaction made, Keybank National Association holds 43,120 shares of NVS stock, worth $4.46 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

43,120

Previous 42,062 2.52%

Holding current value

$4.46 Million

Previous $4.48 Million 10.77%

% of portfolio

0.02%

Previous 0.02%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$106.13 - $120.89 $112,285 - $127,901	1,058 Added 2.52%	43,120 $4.96 Million
Q2 2024 Jul 31, 2024	BUY	$92.57 - $107.37 $107,473 - $124,656	1,161 Added 2.84%	42,062 $4.48 Million
Q1 2024 May 14, 2024	SELL	$95.27 - $108.47 $70,880 - $80,701	-744 Reduced 1.79%	40,901 $3.96 Million
Q4 2023 Feb 13, 2024	BUY	$92.27 - $101.54 $336,139 - $369,910	3,643 Added 9.59%	41,645 $4.2 Million
Q3 2023 Nov 08, 2023	BUY	$94.73 - $105.13 $24,250 - $26,913	256 Added 0.68%	38,002 $3.87 Million
Q2 2023 Aug 01, 2023	SELL	$92.52 - $104.91 $340,658 - $386,278	-3,682 Reduced 8.89%	37,746 $3.81 Million
Q1 2023 May 10, 2023	SELL	$80.03 - $92.81 $81,950 - $95,037	-1,024 Reduced 2.41%	41,428 $3.81 Million
Q4 2022 Jan 31, 2023	SELL	$75.55 - $92.52 $92,624 - $113,429	-1,226 Reduced 2.81%	42,452 $3.85 Million
Q3 2022 Oct 27, 2022	BUY	$74.61 - $87.26 $132,731 - $155,235	1,779 Added 4.25%	43,678 $3.32 Million
Q2 2022 Aug 08, 2022	SELL	$80.52 - $93.75 $169,333 - $197,156	-2,103 Reduced 4.78%	41,899 $3.54 Million
Q1 2022 Apr 28, 2022	SELL	$80.11 - $90.62 $21,629 - $24,467	-270 Reduced 0.61%	44,002 $3.86 Million
Q4 2021 Feb 07, 2022	SELL	$79.7 - $88.13 $66,948 - $74,029	-840 Reduced 1.86%	44,272 $3.87 Million
Q3 2021 Nov 08, 2021	BUY	$81.78 - $95.14 $173,864 - $202,267	2,126 Added 4.95%	45,112 $3.69 Million
Q2 2021 Aug 12, 2021	SELL	$85.24 - $94.15 $28,896 - $31,916	-339 Reduced 0.78%	42,986 $3.92 Million
Q1 2021 May 07, 2021	SELL	$83.5 - $98.47 $343,435 - $405,007	-4,113 Reduced 8.67%	43,325 $3.7 Million
Q4 2020 Feb 09, 2021	SELL	$78.07 - $94.43 $324,458 - $392,451	-4,156 Reduced 8.06%	47,438 $4.48 Million
Q3 2020 Oct 29, 2020	SELL	$82.14 - $91.0 $2,299 - $2,548	-28 Reduced 0.05%	51,594 $4.49 Million
Q2 2020 Aug 10, 2020	SELL	$80.93 - $91.1 $338,206 - $380,706	-4,179 Reduced 7.49%	51,622 $4.51 Million
Q1 2020 May 13, 2020	SELL	$70.67 - $99.01 $112,506 - $157,623	-1,592 Reduced 2.77%	55,801 $4.6 Million
Q4 2019 Feb 05, 2020	BUY	$84.35 - $95.37 $93,206 - $105,383	1,105 Added 1.96%	57,393 $5.44 Million
Q3 2019 Nov 04, 2019	SELL	$85.54 - $94.26 $523,077 - $576,399	-6,115 Reduced 9.8%	56,288 $4.89 Million
Q2 2019 Aug 01, 2019	SELL	$75.4 - $92.8 $111,215 - $136,880	-1,475 Reduced 2.31%	62,403 $5.7 Million
Q1 2019 May 08, 2019	SELL	$75.32 - $86.15 $730,905 - $835,999	-9,704 Reduced 13.19%	63,878 $6.14 Million
Q4 2018 Jan 30, 2019	SELL	$73.66 - $82.02 $72,113 - $80,297	-979 Reduced 1.31%	73,582 $6.31 Million
Q3 2018 Nov 08, 2018	BUY	$66.94 - $77.43 $49,067 - $56,756	733 Added 0.99%	74,561 $6.42 Million
Q2 2018 Aug 08, 2018	SELL	$64.91 - $73.36 $200,052 - $226,095	-3,082 Reduced 4.01%	73,828 $5.58 Million
Q1 2018 May 15, 2018	SELL	$70.39 - $84.15 $374,193 - $447,341	-5,316 Reduced 6.47%	76,910 $6.22 Million
Q4 2017 Feb 08, 2018	SELL	$72.33 - $77.64 $142,128 - $152,562	-1,965 Reduced 2.33%	82,226 $6.9 Million
Q3 2017 Nov 02, 2017	SELL	$74.14 - $77.27 $244,810 - $255,145	-3,302 Reduced 3.77%	84,191 $7.23 Million
Q2 2017 May 14, 2018	SELL	N/A	-474 Reduced 0.54%	87,493 $7.3 Million
Q1 2017 May 14, 2018	SELL	N/A	-2,266 Reduced 2.51%	87,967 $6.53 Million
Q4 2016 May 14, 2018	BUY	N/A	90,233	90,233 $6.57 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.

Account

Keybank National Association Novartis Ag Transaction History